Propafenone for refractory ventricular arrhythmias: Correlation with drug plasma levels during long-term treatment
- 1 November 1984
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 54 (8) , 1008-1014
- https://doi.org/10.1016/s0002-9149(84)80135-6
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Clinical pharmacology of propafenone.Circulation, 1983
- Suppression of ventricular arrhythmias by propafenone, a new antiarrhythmic agent, during acute myocardial infarction in the conscious dog. A comparative study with lidocaine.Circulation, 1982
- Determination of propafenone in serum or plasma by electron-capture gas chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1982
- Can we prevent sudden cardiac death?The American Journal of Cardiology, 1982
- Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugsThe American Journal of Cardiology, 1982
- Evolving concepts of management of stable and potentially lethal arrhythmiasAmerican Heart Journal, 1982
- Ventricular premature complexes and sudden death after myocardial infarction.Circulation, 1981
- Spontaneous variability of complex ventricular arrhythmias detected by long-term electrocardiographic recording.Circulation, 1980
- Antiarrhythmic drug therapy in survivors of prehospital cardiac arrest: comparison of effects on chronic ventricular arrhythmias and recurrent cardiac arrest.Circulation, 1979
- Frequent or complex ventricular ectopy in apparently healthy subjectsThe American Journal of Cardiology, 1976